Cargando…
BIOSOLVE‐IV‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients
OBJECTIVES: We aimed to assess the safety and performance of the Magmaris sirolimus‐eluting bioresorbable magnesium scaffold in a large patient population. BACKGROUND: Magmaris has shown good outcomes in small‐sized controlled trials, but further data are needed to confirm its usability, safety, and...
Autores principales: | Verheye, Stefan, Wlodarczak, Adrian, Montorsi, Piero, Torzewski, Jan, Bennett, Johan, Haude, Michael, Starmer, Gregory, Buck, Thomas, Wiemer, Marcus, Nuruddin, Amin A. B., Yan, Bryan P.‐Y., Lee, Michael K.‐Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359313/ https://www.ncbi.nlm.nih.gov/pubmed/32881396 http://dx.doi.org/10.1002/ccd.29260 |
Ejemplares similares
-
Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12‐month outcomes of BIOSOLVE‐II and BIOSOLVE‐III
por: Haude, Michael, et al.
Publicado: (2018) -
Serial invasive imaging follow‐up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold
por: Tovar Forero, Maria Natalia, et al.
Publicado: (2019) -
Diagnostic role of coronary CT angiography in paroxysmal or first diagnosed atrial fibrillation
por: Rottländer, Dennis, et al.
Publicado: (2021) -
Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020) -
Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent
por: Barkholt, Trine Ø., et al.
Publicado: (2019)